{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:33:39Z","timestamp":1773290019725,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00296-018-4154-6","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T04:55:40Z","timestamp":1536555340000},"page":"2271-2277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center"],"prefix":"10.1007","volume":"38","author":[{"given":"Kazunori","family":"Karasawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"issue":"6","key":"4154_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/0961203310389486","volume":"20","author":"YH Lee","year":"2011","unstructured":"Lee YH, Lee HS, Choi SJ, Dai Ji J, Song GG (2011) Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials. Lupus 20(6):636\u2013640","journal-title":"Lupus"},{"issue":"9","key":"4154_CR2","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013010026","volume":"24","author":"M Lech","year":"2013","unstructured":"Lech M, Anders HJ (2013) The pathogenesis of lupus nephritis. J Am Soc Nephrol 24(9):1357\u20131366","journal-title":"J Am Soc Nephrol"},{"key":"4154_CR3","doi-asserted-by":"publisher","first-page":"419029","DOI":"10.1155\/2014\/419029","volume":"2014","author":"A Mak","year":"2014","unstructured":"Mak A, Kow NY (2014) The pathology of T cells in systemic lupus erythematosus. J Immunol Res 2014:419029","journal-title":"J Immunol Res"},{"issue":"5","key":"4154_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/BOR.0000000000000082","volume":"26","author":"C Konya","year":"2014","unstructured":"Konya C, Paz Z, Tsokos GC (2014) The role of T cells in systemic lupus erythematosus: an update. Curr Opin Rheumatol 26(5):493\u2013501","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"4154_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/ar3251","volume":"13","author":"VR Moulton","year":"2011","unstructured":"Moulton VR, Tsokos GC (2011) Abnormalities of T cell signaling in systemic lupuserythematosus. Arthritis Res Ther 13(2):207","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"4154_CR6","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.4049\/jimmunol.138.10.3247","volume":"138","author":"D Wofsy","year":"1987","unstructured":"Wofsy D, Seaman WE (1987) Reversal of advanced murine lupus in NZB\/NZW F1 mice by treatment with monoclonal antibody to L3T4. J Immunol 138(10):3247\u20133253","journal-title":"J Immunol"},{"issue":"4","key":"4154_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1084\/jem.179.4.1137","volume":"179","author":"AM Jevnikar","year":"1994","unstructured":"Jevnikar AM, Grusby MJ, Glimcher LH (1994) Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med 179(4):1137\u20131143","journal-title":"J Exp Med"},{"issue":"1","key":"4154_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1248\/yakushi.130.113","volume":"130","author":"K Uchida","year":"2010","unstructured":"Uchida K, Asamiya Y, Takei T, Itabashi M, Sugiura H, Tsukada M, Nitta K (2010) Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients. Yakugaku Zasshi 130(1):113\u2013118","journal-title":"Yakugaku Zasshi"},{"issue":"4","key":"4154_CR9","doi-asserted-by":"publisher","first-page":"c330","DOI":"10.1159\/000235952","volume":"113","author":"Y Asamiya","year":"2009","unstructured":"Asamiya Y, Uchida K, Otsubo S, Takei T, Nitta K (2009) Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center. Nephron Clin Pract 113(4):c330\u20136","journal-title":"Nephron Clin Pract"},{"issue":"11","key":"4154_CR10","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271\u20131277","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4154_CR11","first-page":"521","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M, International Society of Nephrology Working Group on the Classification of Lupus Nephritis, Renal Pathology Society Working Group on the Classification of Lupus Nephritis (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65(2):521\u2013530","journal-title":"Renal Pathology Society Working Group on the Classification of Lupus NephritisKidney Int"},{"issue":"6","key":"4154_CR12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982\u2013992","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"4154_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3109\/s10165-009-0218-5","volume":"19","author":"N Miyasaka","year":"2009","unstructured":"Miyasaka N, Kawai S, Hashimoto H (2009) Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study. Mod Rheumatol 19(6):606\u2013615","journal-title":"Mod Rheumatol"},{"issue":"6","key":"4154_CR14","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/ki.1996.528","volume":"50","author":"G Moroni","year":"1996","unstructured":"Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C (1996) \u201cNephritic flares\u201d are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 50(6):2047\u20132053","journal-title":"Kidney Int"},{"issue":"5","key":"4154_CR15","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/ndt\/gfs515","volume":"28","author":"T Takei","year":"2013","unstructured":"Takei T, Itabashi M, Moriyama T, Kojima C, Shiohira S, Shimizu A, Tsuruta Y, Ochi A, Amemiya N, Mochizuki T, Uchida K, Tsuchiya K, Nitta K (2013) Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults. Nephrol Dial Transpl 28(5):1225\u20131232","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"4154_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jama.1981.03310340024021","volume":"245","author":"DJ Wallace","year":"1981","unstructured":"Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL (1981) Systemic lupus erythematosus\u2014survival patterns. Experience with 609 patients. JAMA 245(9):934\u2013938","journal-title":"JAMA"},{"issue":"8","key":"4154_CR17","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/art.38006","volume":"65","author":"CC Mok","year":"2013","unstructured":"Mok CC, Kwok RC, Yip PS (2013) Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum 65(8):2154\u20132160","journal-title":"Arthritis Rheum"},{"issue":"7","key":"4154_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/rheumatology\/ker410","volume":"51","author":"G Ruiz-Irastorza","year":"2012","unstructured":"Ruiz-Irastorza G, Danza A, Khamashta M (2012) Glucocorticoid use and abuse in SLE. Rheumatology (Oxford) 51(7):1145\u20131153","journal-title":"Rheumatology (Oxford)"},{"issue":"20","key":"4154_CR19","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","volume":"365","author":"MA Dooley","year":"2011","unstructured":"Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB, Contreras G, Lisk L, Solomons N, ALMS Group (2011) Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 365(20):1886\u20131895","journal-title":"N Engl J Med"},{"issue":"7","key":"4154_CR20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.7326\/0003-4819-125-7-199610010-00003","volume":"125","author":"MF Gourley","year":"1996","unstructured":"Gourley MF, Austin HA III, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD (1996) Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med 125(7):549\u2013557","journal-title":"Ann Intern Med"},{"issue":"1","key":"4154_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ndt\/gfn565","volume":"24","author":"G Moroni","year":"2009","unstructured":"Moroni G, Doria A, Ponticelli C (2009) Cyclosporine (CsA) in lupus nephritis: assessing the evidence. Nephrol Dial Transpl 24(1):15\u201320","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"4154_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.autrev.2015.09.006","volume":"15","author":"J Hannah","year":"2016","unstructured":"Hannah J, Casian A, D\u2019Cruz D (2016) Tacrolimus use in lupus nephritis: a systematic review and meta-analysis. Autoimmun Rev 15(1):93\u2013101","journal-title":"Autoimmun Rev"},{"key":"4154_CR23","doi-asserted-by":"publisher","first-page":"740619","DOI":"10.1155\/2010\/740619","volume":"2010","author":"LA Lieberman","year":"2010","unstructured":"Lieberman LA, Tsokos GC (2010) The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J Biomed Biotechnol 2010:740619","journal-title":"J Biomed Biotechnol"},{"issue":"6","key":"4154_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrrheum.2010.60","volume":"6","author":"JC Crisp\u00edn","year":"2010","unstructured":"Crisp\u00edn JC, Kyttaris VC, Terhorst C, Tsokos GC (2010) T cells as therapeutic targets in SLE. Nat Rev Rheumatol 6(6):317\u2013325","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"4154_CR25","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.4049\/jimmunol.0900385","volume":"183","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Kyttaris VC, Tsokos GC (2009) The role of IL-23\/IL-17 axis in lupus nephritis. J Immunol 183(5):3160\u20133169","journal-title":"J Immunol"},{"issue":"9","key":"4154_CR26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14(9):931\u2013938","journal-title":"Nat Med"},{"issue":"9","key":"4154_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","volume":"40","author":"T Kino","year":"1987","unstructured":"Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1987) FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 40(9):1249\u20131255","journal-title":"J Antibiot (Tokyo)"},{"issue":"9","key":"4154_CR28","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","volume":"40","author":"T Kino","year":"1987","unstructured":"Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H et al (1987) FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 40(9):1256\u20131265","journal-title":"J Antibiot (Tokyo)"},{"issue":"1","key":"4154_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/0961203306073167","volume":"16","author":"KC Tse","year":"2007","unstructured":"Tse KC, Lam MF, Tang SC, Tang CS, Chan TM (2007) A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade. Lupus 16(1):46\u201351","journal-title":"Lupus"},{"issue":"12","key":"4154_CR30","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/rheumatology\/keu265","volume":"53","author":"DY Yap","year":"2014","unstructured":"Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM (2014) Long-term data on tacrolimus treatment in lupus nephritis. Rheumatology 53(12):2232\u20132237","journal-title":"Rheumatology"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4154-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4154-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4154-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:02:05Z","timestamp":1693872125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4154-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4154"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4154-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"28 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study complied with the guidelines of the Declaration of Helsinki and was approved by the Tokyo Women\u2019s Medical University Ethics Committee under Approval Number #4226, January 6, 2017. We received oral consent from all patients and provided them with the opportunity to opt out.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}